Literature DB >> 17207691

PET/CT in non-small cell lung cancer staging-promises and problems.

A Devaraj1, G J R Cook, D M Hansell.   

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) has many advantages over solitary PET and CT, which has led it to become an increasingly established imaging technique in the management of many cancers. This article will review the evidence for the role of (18)F-fluorodeoxyglucose PET/CT in non-small cell lung cancer staging, examining its strengths, weaknesses and cost-effectiveness.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17207691     DOI： 10.1016/j.crad.2006.09.015

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


  15 in total

Review 1.  Multiplexed imaging in cancer diagnosis: applications and future advances.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Satomi Kawamoto
Journal:  Lancet Oncol       Date:  2010-03-24       Impact factor: 41.316

2.  Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomography.

Authors:  Dan Shao; Shu-Xia Wang; Chang-Hong Liang; Qiang Gao
Journal:  J Nucl Cardiol       Date:  2011-06-08       Impact factor: 5.952

3.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

Review 4.  The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.

Authors:  Sara Volpi; Jason M Ali; Angela Tasker; Adam Peryt; Giuseppe Aresu; Aman S Coonar
Journal:  Ann Transl Med       Date:  2018-03

5.  Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.

Authors:  A Abramyuk; S Appold; K Zöphel; M Baumann; N Abolmaali
Journal:  Strahlenther Onkol       Date:  2013-01-19       Impact factor: 3.621

Review 6.  A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?

Authors:  Astrid Langer
Journal:  BMC Health Serv Res       Date:  2010-10-08       Impact factor: 2.655

7.  Primary lung tumour visualised by transthoracic echocardiography.

Authors:  Magnus Dencker; Carin Cronberg; Sabine Damm; Sven Valind; Monica Wadbo
Journal:  Cardiovasc Ultrasound       Date:  2008-12-16       Impact factor: 2.062

Review 8.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

9.  Positron emission tomography in the management of lung cancer.

Authors:  Vahid Reza Dabbagh Kakhki
Journal:  Ann Thorac Med       Date:  2007-04       Impact factor: 2.219

10.  Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.

Authors:  Meng Li; Ning Wu; Rong Zheng; Ying Liang; Ying Liu; Wenjie Zhang; Ni Li; Ping Zhao
Journal:  Cancer Imaging       Date:  2013-02-07       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.